Green Tea Compound shows promise in leukemia treatment

In a clinical trail conducted at Mayo Clinic, researchers found a compound in green tea reduced enlarged lymph nodes in 70 percent of patients.

The compound curtails the survival of leukemia cells in patients diagnosed with Chronic Lymphocytic Leukemia. The current trial is the first time green tea extract has been studied in human patients.

While recommendations for the use of green tea for CLL patients cannot be officially recommended before phase three trials, anyone wishing to use a supplement can consult their oncologist about it and receive any recommended laboratory monitoring.

As time goes by, new treatments and drugs are found to be useful for the treatment of various forms of blood cancer. Tax-deductible donations may be made to the Leukemia Lymphoma Society to help fund research and patient services.

For further information regarding blood cancer and the green tea compound study are offered on the following links.

To help fund my walk to fight leukemia go to:  My Fundraising Page.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s